Search research articles
Contact Us
Filters
Showing results (141-150 of 209) with videos related to
Page
of 21
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
October 13, 2009
External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomy
Hendrik Isbarn, Pierre I Karakiewicz, Jochen Walz, et al.
The Prostate
|
July 24, 2012
External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection
Jens Hansen, Michael Rink, Marco Bianchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 14, 2024
Real-World Comparison of Cabazitaxel Versus <sup>177</sup>Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer
Mike Wenzel, Florestan Koll, Benedikt Hoeh, et al.
Frontiers in Oncology
|
May 10, 2021
Impact of Time to Castration Resistance on Survival in Metastatic Hormone Sensitive Prostate Cancer Patients in the Era of Combination Therapies
Mike Wenzel, Felix Preisser, Benedikt Hoeh, et al.
European Urology
|
May 18, 2012
Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients
Thorsten Schlomm, Pierre Tennstedt, Caroline Huxhold, et al.
European Urology Focus
|
January 8, 2018
The Impact of Lymph Node Metastases Burden at Radical Prostatectomy
Felix Preisser, Michele Marchioni, Sebastiano Nazzani, et al.
The Prostate
|
September 3, 2010
High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer
Sarah Minner, Corinna Wittmer, Markus Graefen, et al.
The Journal of Urology
|
September 9, 2014
Use of phosphodiesterase type 5 inhibitors may adversely impact biochemical recurrence after radical prostatectomy
Uwe Michl, Frederike Molfenter, Markus Graefen, et al.
The American Journal of Pathology
|
January 1, 2014
βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion
Maria C Tsourlakis, Philipp Weigand, Katharina Grupp, et al.
Nuklearmedizin. Nuclear Medicine
|
August 20, 2021
Clinical impact of whole-body 68Ga-PSMA I&T PET/CT: lesion frequency and added benefit in lower extremities
Lara Franziska Stolzenbach, Florian Löcherbach, Katharina Wargenau, et al.
Page
of 21
Search research articles
Search
Showing results (141-150 of 209) with videos related to
Sort By:
Page
of 21
International Journal of Radiation Oncology, Biology, Physics
|
October 13, 2009
External validation of a preoperative nomogram for prediction of the risk of recurrence after radical prostatectomy
Hendrik Isbarn, Pierre I Karakiewicz, Jochen Walz, et al.
The Prostate
|
July 24, 2012
External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection
Jens Hansen, Michael Rink, Marco Bianchi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 14, 2024
Real-World Comparison of Cabazitaxel Versus <sup>177</sup>Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer
Mike Wenzel, Florestan Koll, Benedikt Hoeh, et al.
Frontiers in Oncology
|
May 10, 2021
Impact of Time to Castration Resistance on Survival in Metastatic Hormone Sensitive Prostate Cancer Patients in the Era of Combination Therapies
Mike Wenzel, Felix Preisser, Benedikt Hoeh, et al.
European Urology
|
May 18, 2012
Neurovascular structure-adjacent frozen-section examination (NeuroSAFE) increases nerve-sparing frequency and reduces positive surgical margins in open and robot-assisted laparoscopic radical prostatectomy: experience after 11,069 consecutive patients
Thorsten Schlomm, Pierre Tennstedt, Caroline Huxhold, et al.
European Urology Focus
|
January 8, 2018
The Impact of Lymph Node Metastases Burden at Radical Prostatectomy
Felix Preisser, Michele Marchioni, Sebastiano Nazzani, et al.
The Prostate
|
September 3, 2010
High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer
Sarah Minner, Corinna Wittmer, Markus Graefen, et al.
The Journal of Urology
|
September 9, 2014
Use of phosphodiesterase type 5 inhibitors may adversely impact biochemical recurrence after radical prostatectomy
Uwe Michl, Frederike Molfenter, Markus Graefen, et al.
The American Journal of Pathology
|
January 1, 2014
βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion
Maria C Tsourlakis, Philipp Weigand, Katharina Grupp, et al.
Nuklearmedizin. Nuclear Medicine
|
August 20, 2021
Clinical impact of whole-body 68Ga-PSMA I&T PET/CT: lesion frequency and added benefit in lower extremities
Lara Franziska Stolzenbach, Florian Löcherbach, Katharina Wargenau, et al.
Page
of 21